Literature DB >> 14736641

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

D B Dunger1, M A Sperling, C L Acerini, D J Bohn, D Daneman, T P A Danne, N S Glaser, R Hanas, R L Hintz, L L Levitsky, M O Savage, R C Tasker, J I Wolfsdorf.   

Abstract

Diabetic ketoacidosis (DKA) is the leading cause of morbidity and mortality in children with type 1 diabetes mellitus (TIDM). Mortality is predominantly related to the occurrence of cerebral oedema; only a minority of deaths in DKA are attributed to other causes. Cerebral oedema occurs in about 0.3-1% of all episodes of DKA, and its aetiology, pathophysiology, and ideal method of treatment are poorly understood. There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral oedema, and the appropriate site(s) for children with DKA to be managed. There is agreement that prevention of DKA and reduction of its incidence should be a goal in managing children with diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736641      PMCID: PMC1719805          DOI: 10.1136/adc.2003.044875

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  102 in total

1.  ON DIABETIC ACIDOSIS: A Detailed Study of Electrolyte Balances Following the Withdrawal and Reestablishment of Insulin Therapy.

Authors:  D W Atchley; R F Loeb; D W Richards; E M Benedict; M E Driscoll
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808

2.  Metabolic studies in severe diabetic ketosis.

Authors:  J D N NABARRO; A G SPENCER; J M STOWERS
Journal:  Q J Med       Date:  1952-04

3.  Causes of death in children with insulin dependent diabetes 1990-96.

Authors:  J A Edge; M E Ford-Adams; D B Dunger
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

4.  Oxygen availability from the blood and the effect of phosphate replacement on erythrocyte 2,3-diphosphoglycerate and haemoglobin-oxygen affinity in diabetic ketoacidosis.

Authors:  O M Gibby; K E Veale; T M Hayes; J G Jones; C A Wardrop
Journal:  Diabetologia       Date:  1978-11       Impact factor: 10.122

5.  Correlates of brain edema in uncontrolled IDDM.

Authors:  J A Durr; W H Hoffman; A H Sklar; T el Gammal; C M Steinhart
Journal:  Diabetes       Date:  1992-05       Impact factor: 9.461

6.  Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group.

Authors:  J Komulainen; R Lounamaa; M Knip; E A Kaprio; H K Akerblom
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

7.  Ketoacidosis occurring in newly diagnosed and established diabetic children.

Authors:  C P Smith; D Firth; S Bennett; C Howard; P Chisholm
Journal:  Acta Paediatr       Date:  1998-05       Impact factor: 2.299

8.  Subclinical brain swelling in children during treatment of diabetic ketoacidosis.

Authors:  E J Krane; M A Rockoff; J K Wallman; J I Wolfsdorf
Journal:  N Engl J Med       Date:  1985-05-02       Impact factor: 91.245

9.  An approach to prevention of recurrent diabetic ketoacidosis in the pediatric population.

Authors:  M P Golden; A J Herrold; D P Orr
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

10.  Phosphate replacement during treatment of diabetic ketosis. Effects on calcium and phosphorus homeostasis.

Authors:  D J Becker; D R Brown; B H Steranka; A L Drash
Journal:  Am J Dis Child       Date:  1983-03
View more
  46 in total

1.  The influence of hyperchloraemia on acid base interpretation in diabetic ketoacidosis.

Authors:  Dan Taylor; Andrew Durward; Shane M Tibby; Kentigern Thorburn; Fiona Holton; Iain C Johnstone; Ian A Murdoch
Journal:  Intensive Care Med       Date:  2006-01-31       Impact factor: 17.440

2.  Metabolic acidosis mimicking diabetic ketoacidosis after use of calorie-free mineral water.

Authors:  Berna Eren Fidanci; Erkan Sari; Ediz Yesilkaya
Journal:  Eur J Pediatr       Date:  2013-07-12       Impact factor: 3.183

3.  Evaluation of the two-bag system for fluid management in pediatric patients with diabetic ketoacidosis.

Authors:  Tsz-Yin So; Elizabeth Grunewalder
Journal:  J Pediatr Pharmacol Ther       Date:  2009-04

4.  Diabetic Ketoacidosis in children admitted to Pediatric Intensive Care Unit of King Fahad Hospital, Al-Baha, Saudi Arabia: Precipitating factors, epidemiological parameters and clinical presentation.

Authors:  Satti Abdulrahim Satti; Imad Yassin Saadeldin; Ali Saeed Dammas
Journal:  Sudan J Paediatr       Date:  2013

5.  Severity of clinical presentation in youth with type 1 diabetes is associated with differences in brain structure.

Authors:  Alejandro F Siller; Heather Lugar; Jerrel Rutlin; Jonathan M Koller; Katherine Semenkovich; Neil H White; Ana Maria Arbelaez; Joshua Shimony; Tamara Hershey
Journal:  Pediatr Diabetes       Date:  2016-08-02       Impact factor: 4.866

6.  Clinical profile of diabetic ketoacidosis in Indian children.

Authors:  Sandeep Kumar Kanwal; Ajay Bando; Virendra Kumar
Journal:  Indian J Pediatr       Date:  2011-12-30       Impact factor: 1.967

7.  Clinical presentation and memory function in youth with type 1 diabetes.

Authors:  Katherine Semenkovich; Allison Bischoff; Tasha Doty; Suzanne Nelson; Alejandro F Siller; Tamara Hershey; Ana Maria Arbeláez
Journal:  Pediatr Diabetes       Date:  2015-09-17       Impact factor: 4.866

8.  Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.

Authors:  S Fredheim; J Johannesen; A Johansen; L Lyngsøe; H Rida; M L M Andersen; M H Lauridsen; B Hertz; N H Birkebæk; B Olsen; H B Mortensen; J Svensson
Journal:  Diabetologia       Date:  2013-02-07       Impact factor: 10.122

9.  Management of diabetic ketoacidosis in PICU.

Authors:  R R Jahagirdar; V V Khadilkar; A V Khadilkar; S K Lalwani
Journal:  Indian J Pediatr       Date:  2007-06       Impact factor: 1.967

Review 10.  Management of diabetic ketoacidosis in children and adolescents.

Authors:  Nicole A Sherry; Lynne L Levitsky
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.